Holen Sie sich die Stockscreener-App
1.97
1.99%
-0.04
Handel nachbörslich:
1.98
0.01
+0.51%
Finanzdaten der Ovid Therapeutics Inc-Aktie (OVID)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.132
|
- | 0.13 | 0.076 | 0.173 |
Operating Expenses
|
12.65
|
- | 12.68 | 10.80 | 13.40 |
| Benefits Costs and Expenses |
12.29
|
- | 10.37 | 9.329 | 14.18 |
| Costs And Expenses |
12.29
|
- | 10.37 | 9.329 | 14.18 |
| Operating Income/Loss |
-12.52
|
- | -12.55 | -10.72 | -13.23 |
| Income/Loss From Continuing Operations Before Tax |
159.56%
-12.16
|
-4.684 | -10.23 | -9.253 | -14.01 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
159.56%
-12.16
|
-4.684 | -10.23 | -9.253 | -14.01 |
|
Net Income/Loss
|
159.56%
-12.16
|
-4.684 | -10.23 | -9.253 | -14.01 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | -0.458 | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):